Physician profile
Fabio Cominelli
NPI 1912042904
$15,365.85
in general payments reported to CMS, 2019-2025
5 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.49 · 2021: $1,200 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Consulting Fee: $2,266 · Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,667.00 |
| Consulting Fee | $2,266.00 |
| Food and Beverage | $198.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma Corporation | $14,087.44 | 2025 | |
| Pfizer INC. | $1,200.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $34.49 | 2019 | |
| Lilly USA, LLC | $26.62 | 2025 | Omvoh |
| Abbott Laboratories | $17.30 | 2025 | Alinity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fabio Cominelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.